MedPath

Effects of a protocol of respiratory care in patients with Amyotrophic Lateral Sclerosis

Not Applicable
Conditions
Amyotrophic lateral sclerosis, pulmonary capacity, cough
G00-G99
Registration Number
RBR-3z23ts
Lead Sponsor
niversidade Federal do Rio Grande do Norte
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Inclusion criteria for the study were patients with ALS, between 18 and 70 years old, with good cognitive level to understand the evaluative tests; patients not restricted to bed; the presence of a responsible caregiver who accepts the training and follows the program; have a telephone to contact the service team.

Exclusion Criteria

Will be excluded from the study volunteers who are unable to perform the requested maneuvers correctly or who give up performing them during the execution for evaluation. Patients with cardiac, respiratory, musculoskeletal comorbidities, intellectual comprehension difficulty or dementia evaluated, with any other comorbidity that prevents them from performing the tests or who have difficulty performing the tests; and, smoking patients. Patients residing in regions that do not have rear medical staff in the city or in a nearby urban center; patients residing in regions of high hazard or difficult for physiotherapists to access.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak cough flow in liters/minute by optoelectronic plethysmograph analysis.;Physical function through the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised - ALSFRS-R.;Number of exacerbations (acute) of the patients through urgent and emergency medical assistance.
Secondary Outcome Measures
NameTimeMethod
Chest wall kinematics during Cough Assist assisted coughing by optoelectronic plethysmography (BTS Bioengineering, Italy).;The absolute and predicted Forced Vital Capacity (FVC), forced expiratory volume in the 1st second (FEV1) and FEV1/FVC by spirometry.;Respiratory muscle strength through maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), sniff nasal inspiratory pressure (SNIP) and nasal expiratory pressure using the manovacuometer.;Demographic (age and gender), anthropometric assessments (height and weight) and body mass index
© Copyright 2025. All Rights Reserved by MedPath